To be or not to be resilient in familial hypercholesterolaemia: implications for the management

Affiliations

Editorial

Giuseppe Mercuro et al. Eur J Prev Cardiol. 2022.

. 2022 May 5;29(5):793-794.

doi: 10.1093/eurjpc/zwab197.

¹ Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, SS 554, Bivio Sestu, 09042 Monserrato (CA), Sardinia, Italy.

No abstract available

Comment on

A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort.
Pérez de Isla L, Watts GF, Muñiz-Grijalvo O, Díaz-Díaz JL, Alonso R, Zambón D, Fuentes-Jimenez F, Mauri M, Padró T, Vidal-Pardo JI, Barba MA, Ruiz-Pérez E, Michán A, Mediavilla JD, Hernandez AM, Romero-Jimenez MJ, Badimon L, Mata P; SAFEHEART Investigators. Pérez de Isla L, et al. Eur J Prev Cardiol. 2022 May 5;29(5):795-801. doi: 10.1093/eurjpc/zwab185. Eur J Prev Cardiol. 2022. PMID: 34864959